Biogen is providing its much-debated Alzheimer's drug Aduhelm free of charge for some patients as it awaits claim reviews by Medicare, according to an Aug. 30 Barron's report.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,